Literature DB >> 29797516

Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Emilio Molina-Molina1, Raquel Lunardi Baccetto1, David Q-H Wang2, Ornella de Bari1, Marcin Krawczyk3,4, Piero Portincasa1.   

Abstract

BACKGROUND: Physical inactivity puts the populations at risk of several health problems, while regular physical activity brings beneficial effects on cardiovascular disease, mortality and other health outcomes, including obesity, glycaemic control and insulin resistance. The hepatobiliary tract is greatly involved in several metabolic aspects which include digestion and absorption of nutrients in concert with intestinal motility, bile acid secretion and flow across the enterohepatic circulation and intestinal microbiota. Several metabolic abnormalities, including nonalcoholic fatty liver as well as cholesterol cholelithiasis, represent two conditions explained by changes of the aforementioned pathways.
MATERIALS AND METHODS: This review defines different training modalities and discusses the effects of physical activity in two metabolic disorders, that is nonalcoholic fatty liver disease (NAFLD) and cholelithiasis. Emphasis is given to pathogenic mechanisms involving intestinal bile acids, microbiota and inflammatory status.
RESULTS: A full definition of physical activity includes the knowledge of aerobic and endurance exercise, metabolic equivalent tasks, duration, frequency and intensity, beneficial and harmful effects. Physical activity influences the hepatobiliary-gut axis at different levels and brings benefits to fat distribution, liver fat and gallbladder disease while interacting with bile acids as signalling molecules, intestinal microbiota and inflammatory changes in the body.
CONCLUSIONS: Several beneficial effects of physical activity are anticipated on metabolic disorders linking liver steatosis, gallstone disease, gut motility, enterohepatic circulation of signalling bile acids in relation to intestinal microbiota and inflammatory changes.
© 2018 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  G protein-coupled bile acid receptor-1; bile acids; farnesoid X receptor; gallstone disease; gut microbiota; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2018        PMID: 29797516      PMCID: PMC8118139          DOI: 10.1111/eci.12958

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  184 in total

1.  2011 Compendium of Physical Activities: a second update of codes and MET values.

Authors:  Barbara E Ainsworth; William L Haskell; Stephen D Herrmann; Nathanael Meckes; David R Bassett; Catrine Tudor-Locke; Jennifer L Greer; Jesse Vezina; Melicia C Whitt-Glover; Arthur S Leon
Journal:  Med Sci Sports Exerc       Date:  2011-08       Impact factor: 5.411

2.  Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine.

Authors:  Romain Meeusen; Martine Duclos; Carl Foster; Andrew Fry; Michael Gleeson; David Nieman; John Raglin; Gerard Rietjens; Jürgen Steinacker; Axel Urhausen
Journal:  Med Sci Sports Exerc       Date:  2013-01       Impact factor: 5.411

3.  Exercise and associated dietary extremes impact on gut microbial diversity.

Authors:  Siobhan F Clarke; Eileen F Murphy; Orla O'Sullivan; Alice J Lucey; Margaret Humphreys; Aileen Hogan; Paula Hayes; Maeve O'Reilly; Ian B Jeffery; Ruth Wood-Martin; David M Kerins; Eamonn Quigley; R Paul Ross; Paul W O'Toole; Michael G Molloy; Eanna Falvey; Fergus Shanahan; Paul D Cotter
Journal:  Gut       Date:  2014-06-09       Impact factor: 23.059

4.  Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

Authors:  Paola Loria; Amedeo Lonardo; Silvia Lombardini; Lucia Carulli; Annamaria Verrone; Dorval Ganazzi; Antonia Rudilosso; Roberto D'Amico; Marco Bertolotti; Nicola Carulli
Journal:  J Gastroenterol Hepatol       Date:  2005-08       Impact factor: 4.029

Review 5.  Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract.

Authors:  H P Peters; W R De Vries; G P Vanberge-Henegouwen; L M Akkermans
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

6.  Relationship of sitting time and physical activity with non-alcoholic fatty liver disease.

Authors:  Seungho Ryu; Yoosoo Chang; Hyun-Suk Jung; Kyung Eun Yun; Min-Jung Kwon; Yuni Choi; Chan-Won Kim; Juhee Cho; Byung-Seong Suh; Yong Kyun Cho; Eun Chul Chung; Hocheol Shin; Yeon Soo Kim
Journal:  J Hepatol       Date:  2015-09-15       Impact factor: 25.083

7.  Physical activity and gallbladder disease determined by ultrasonography.

Authors:  Andrea M Kriska; Jennifer S Brach; Betty J Jarvis; James E Everhart; Anthony Fabio; Caroline R Richardson; Barbara V Howard
Journal:  Med Sci Sports Exerc       Date:  2007-11       Impact factor: 5.411

Review 8.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

9.  Cholecystokinin, gastrin and stress hormone responses in marathon runners.

Authors:  E Philipp; T Wilckens; E Friess; P Platte; K M Pirke
Journal:  Peptides       Date:  1992 Jan-Feb       Impact factor: 3.750

10.  Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Authors:  Hui-Jie Zhang; Jiang He; Ling-Ling Pan; Zhi-Min Ma; Cheng-Kun Han; Chung-Shiuan Chen; Zheng Chen; Hai-Wei Han; Shi Chen; Qian Sun; Jun-Feng Zhang; Zhi-Bin Li; Shu-Yu Yang; Xue-Jun Li; Xiao-Ying Li
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

View more
  16 in total

Review 1.  Bile acids and the gut microbiota: metabolic interactions and impacts on disease.

Authors:  Stephanie L Collins; Jonathan G Stine; Jordan E Bisanz; C Denise Okafor; Andrew D Patterson
Journal:  Nat Rev Microbiol       Date:  2022-10-17       Impact factor: 78.297

Review 2.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

3.  Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver.

Authors:  Harshitha Shanmugam; Agostino Di Ciaula; Domenica Maria Di Palo; Emilio Molina-Molina; Gabriella Garruti; Maria Felicia Faienza; Karel vanErpecum; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2021-05-25       Impact factor: 5.722

4.  Big data and analysis of risk factors for gallbladder disease in the young generation of Korea.

Authors:  Hyung Sun Kim; Seong Kyung Cho; Chang Soo Kim; Joon Seong Park
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 5.  Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Authors:  Agostino Di Ciaula; Salvatore Passarella; Harshitha Shanmugam; Marica Noviello; Leonilde Bonfrate; David Q-H Wang; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 6.  Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ignazio Grattagliano; Agostino Di Ciaula; Jacek Baj; Emilio Molina-Molina; Harshitha Shanmugam; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Methods Mol Biol       Date:  2021

7.  Childhood obesity, cardiovascular and liver health: a growing epidemic with age.

Authors:  Maria Felicia Faienza; Mariangela Chiarito; Emilio Molina-Molina; Harshitha Shanmugam; Frank Lammert; Marcin Krawczyk; Gabriele D'Amato; Piero Portincasa
Journal:  World J Pediatr       Date:  2020-02-04       Impact factor: 9.186

8.  Physical activity can reduce the prevalence of gallstone disease among males: An observational study.

Authors:  Oh-Sung Kwon; Young-Kyu Kim; Kyu Hee Her; Hyeon Ju Kim; Seung Duk Lee
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

Review 9.  COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics.

Authors:  Piero Portincasa; Marcin Krawczyk; Wiktor Smyk; Frank Lammert; Agostino Di Ciaula
Journal:  Eur J Clin Invest       Date:  2020-08-26       Impact factor: 5.722

Review 10.  Recent advances in understanding and managing cholesterol gallstones.

Authors:  Agostino Di Ciaula; Piero Portincasa
Journal:  F1000Res       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.